Literature DB >> 22517367

Lumenal lipid metabolism: implications for lipoprotein assembly.

Richard Lehner1, Jihong Lian, Ariel D Quiroga.   

Abstract

Overproduction of apolipoprotein B (apoB)-containing lipoproteins by the liver and the intestine is 1 of the hallmarks of insulin resistance and type 2 diabetes and a well-established risk factor of cardiovascular disease. The assembly of apoB lipoproteins is regulated by the availability of lipids that form the neutral lipid core (triacylglycerol and cholesteryl ester) and the limiting lipoprotein monolayer (phospholipids and cholesterol). Although tremendous advances have been made over the past decade toward understanding neutral lipid and phospholipid biosynthesis and neutral lipid storage in cytosolic lipid droplets (LDs), little is known about the mechanisms that govern the transfer of lipids to the lumen of the endoplasmic reticulum for apoB lipidation. ApoB-synthesizing organs can deposit synthesized neutral lipids into at least 3 different types of LDs, each decorated with a subset of specific proteins: perilipin-decorated cytosolic LDs, and 2 types of LDs formed in the lumen of the endoplasmic reticulum, the secretion-destined LDs containing apoB, and resident lumenal LDs coated with microsomal triglyceride transfer protein and exchangeable apolipoproteins. This brief review will address the current knowledge of lumenal lipid metabolism in the context of apoB assembly and lipid storage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22517367     DOI: 10.1161/ATVBAHA.111.241497

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  27 in total

1.  To absorb fat - supersize my lipid droplets.

Authors:  Ira J Goldberg; M Mahmood Hussain
Journal:  J Clin Invest       Date:  2018-12-03       Impact factor: 14.808

2.  The epigenetic drug 5-azacytidine interferes with cholesterol and lipid metabolism.

Authors:  Steve Poirier; Samaneh Samami; Maya Mamarbachi; Annie Demers; Ta Yuan Chang; Dennis E Vance; Grant M Hatch; Gaétan Mayer
Journal:  J Biol Chem       Date:  2014-05-22       Impact factor: 5.157

Review 3.  Lipid transfer proteins in the assembly of apoB-containing lipoproteins.

Authors:  Alaa Sirwi; M Mahmood Hussain
Journal:  J Lipid Res       Date:  2018-04-12       Impact factor: 5.922

Review 4.  Recent discoveries on absorption of dietary fat: Presence, synthesis, and metabolism of cytoplasmic lipid droplets within enterocytes.

Authors:  Theresa D'Aquila; Yu-Han Hung; Alicia Carreiro; Kimberly K Buhman
Journal:  Biochim Biophys Acta       Date:  2016-04-20

Review 5.  Intestinal lipid absorption and lipoprotein formation.

Authors:  M Mahmood Hussain
Journal:  Curr Opin Lipidol       Date:  2014-06       Impact factor: 4.776

Review 6.  The ins and outs of hepatitis C virus entry and assembly.

Authors:  Brett D Lindenbach; Charles M Rice
Journal:  Nat Rev Microbiol       Date:  2013-09-10       Impact factor: 60.633

Review 7.  Intestinal triacylglycerol synthesis in fat absorption and systemic energy metabolism.

Authors:  Chi-Liang Eric Yen; David W Nelson; Mei-I Yen
Journal:  J Lipid Res       Date:  2014-09-17       Impact factor: 5.922

8.  Inhibition of apolipoprotein B synthesis stimulates endoplasmic reticulum autophagy that prevents steatosis.

Authors:  Donna M Conlon; Tiffany Thomas; Tatyana Fedotova; Antonio Hernandez-Ono; Gilbert Di Paolo; Robin B Chan; Kelly Ruggles; Sarah Gibeley; Jing Liu; Henry N Ginsberg
Journal:  J Clin Invest       Date:  2016-09-06       Impact factor: 14.808

9.  TM6SF2 rs58542926 impacts lipid processing in liver and small intestine.

Authors:  Elizabeth A O'Hare; Rongze Yang; Laura M Yerges-Armstrong; Urmila Sreenivasan; Rebecca McFarland; Carmen C Leitch; Meredith H Wilson; Shilpa Narina; Alexis Gorden; Kathy A Ryan; Alan R Shuldiner; Steve A Farber; G Craig Wood; Christopher D Still; Glenn S Gerhard; Janet D Robishaw; Carole Sztalryd; Norann A Zaghloul
Journal:  Hepatology       Date:  2017-03-22       Impact factor: 17.425

10.  Effects of chlorpyrifos on non-cholinergic toxicity endpoints in immortalized and primary rat hepatocytes under normal and hepatosteatotic conditions.

Authors:  SandeepReddy Kondakala; Lucie Henein; Erin McDevitt; Matthew K Ross; George Eli Howell
Journal:  Toxicol In Vitro       Date:  2022-02-11       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.